University of Catania

- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1434-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.unict.it/en
Clinical Trials
64
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (43 trials with phase data)• Click on a phase to view related trials
Impact of Minimally Non-surgical Periodontal Treatment on Residual Pockets
- Conditions
- Pocket, PeriodontalPeriodontitis
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 64
- Registration Number
- NCT06993519
- Locations
- 🇮🇹
Policlinico G. Rodolico, Catania, Italy
Impact of Minimally Invasive Non-surgical Periodontal Treatment on Infrabony Defects
- Conditions
- Periodontal Intrabony Defect
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 52
- Registration Number
- NCT06992219
- Locations
- 🇮🇹
AOU Policlinico G. Rodolico, Catania, Italy
Analysis of Line-Field Confocal Optical Coherence Tomography (LC-OCT) in Characterization of Gingival Systemic Health, Gingivitis and Periodontitis
- Conditions
- Gingival Diseases
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 60
- Registration Number
- NCT06831487
- Locations
- 🇮🇹
Policlinico G. Rodolico, Catania, Italy
Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis
- Conditions
- MucositisPeri Implant Mucositis
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 54
- Registration Number
- NCT06725095
- Locations
- 🇮🇹
Policlinico G. Rodolico, Catania, Ct, Italy
Eye Soft Surgery for Facial Sinkynesis
- Conditions
- Facial ParalysisSinkynesis
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 25
- Registration Number
- NCT06538103
- Locations
- 🇮🇹
Arianna Di Stadio, Catania, Sicily, Italy
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
Real-World Study Shows Pepaxti Effective in Heavily Pretreated Multiple Myeloma Patients
Italian researchers report promising results for Pepaxti (melflufen) in treating triple-class refractory multiple myeloma patients, achieving a 37.5% overall response rate despite patients having received a median of 3.5 prior therapies.